SEC Form 4 · accession 0001127602-15-023277
Salesforce, Inc. · CRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Benioff
Officer — Chairman of the Board & CEO · Director
Period of report
Jul 20, 2015
Accepted (ET)
Jul 22, 2015 · 9:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001108524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 20, 2015 | M | 12,500 | $35.625 | A | 37,675,900 | D | |
| Common StockF1,F2 | Jul 20, 2015 | S | 12,500 | $72.8764 | D | 37,663,400 | D | |
| Common StockF1 | Jul 21, 2015 | M | 12,500 | $35.625 | A | 37,675,900 | D | |
| Common StockF1,F3 | Jul 21, 2015 | S | 7,700 | $73.3516 | D | 37,668,200 | D | |
| Common StockF1,F4 | Jul 21, 2015 | S | 4,800 | $73.6744 | D | 37,663,400 | D | |
| Common StockF1 | Jul 22, 2015 | M | 12,500 | $35.625 | A | 37,675,900 | D | |
| Common StockF1,F5 | Jul 22, 2015 | S | 12,300 | $73.8586 | D | 37,663,600 | D | |
| Common StockF1,F6 | Jul 22, 2015 | S | 200 | $74.375 | D | 37,663,400 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F1,F7 | $35.625 | Jul 20, 2015 | M | 12,500 | D | Nov 23, 2011 | Nov 23, 2015 | Common Stock | 12,500 | 712,500 | D |
| Non-qualified Stock Option (Right to Buy)F1,F7 | $35.625 | Jul 21, 2015 | M | 12,500 | D | Nov 23, 2011 | Nov 23, 2015 | Common Stock | 12,500 | 700,000 | D |
| Non-qualified Stock Option (Right to Buy)F1,F7 | $35.625 | Jul 22, 2015 | M | 12,500 | D | Nov 23, 2011 | Nov 23, 2015 | Common Stock | 12,500 | 687,500 | D |
Explanation of responses
- F1Pursuant to a 10b5-1 Plan.
- F2Weighted average price. These shares were sold in multiple transactions at prices ranging from $72.4900 to $73.1900 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F3Weighted average price. These shares were sold in multiple transactions at prices ranging from $72.5100 to $73.5000 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F4Weighted average price. These shares were sold in multiple transactions at prices ranging from $73.5100 to $73.8700 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F5Weighted average price. These shares were sold in multiple transactions at prices ranging from $73.3700 to $74.3400 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F6Weighted average price. These shares were sold in multiple transactions at prices ranging from $74.37 to $74.3800 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F7Option is exercisable and vests over four years at the rate of 25% on November 23, 2011, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.